American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
China said on Saturday it strongly opposes Washington's decision to levy additional tariffs on $550 billion worth of Chinese goods and warned the United States of consequences...Politicsread more
President Donald Trump called for legislation that would lower the prices of pharmaceutical drugs in the U.S. in his State of the Union address on Tuesday night.
"It is unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place," Trump said. "This is wrong, unfair, and together we will stop it."
"I am asking Congress to pass legislation that finally takes on the problem of global freeloading and delivers fairness and price transparency for American patients," Trump added. "We should also require drug companies, insurance companies, and hospitals to disclose real prices to foster competition and bring costs way down."
Trump's remarks on drug pricing come after the administration proposed a ban on so-called backdoor deals cut by pharmaceutical companies with middlemen who get preferred status for their drugs through Medicare.
Right now, drug companies pay rebates to pharmacy benefit management (PBM) companies like CVS Health to include their medications on Medicare Part D plans. The Trump administration's proposal would leave PBMs receiving just a flat fee for including drugs on those plans. It would also pass approximately $29 billion in drug-company rebates to consumers.
Wall Street strategists said ahead of the speech that Trump's comments on drug pricing, along with infrastructure and trade, could be market moving. Strategists warned major drug stocks like Merck and Pfizer, as well as related companies like CVS Health and UnitedHealth, could come under pressure if Trump came out strong against high drug prices.
The speech comes more than a week after the longest government shutdown in U.S. history ended. On Jan. 25, both Trump and Democratic leaders in Congress agreed to re-open the government for three weeks.
This is breaking news. Please check back for updates.